On-line Education Teaches on Clostridium difficile

OSUWexnerbloglogo2014 On-line Education Teaches on Clostridium difficile. On this CME webcast, we are going to discuss Clostridioides difficile: how to diagnosis it, how to treat it, and most importantly, how to prevent it in your patients and in your hospital. Let me welcome today’s guests. Lisa Hines is an infection preventionist in the Department of Clinical Epidemiology at the OSU Wexner Medical Center. And Dr. Christina Liscynesky is an Assistant Professor of Internal Medicine from the Division of Infectious Disease and the Associate Medical Director of Clinical Epidemiology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the difference between C diff assays; UNDERSTAND the different medications used to treat C. diff.; DESCRIBE the pathophysiology of Clostridioides difficile infection (CDI); and IDENTIFY at least two infection prevention measures to decrease the spread of Clostridioides difficile infections (CDI) in the healthcare setting.

You’ll also learn about the following:

  • Risk factors for C. diff
  • Diagnostic challenges
  • Mattresses and C. diff
  • Ultraviolet light emitters
  • Probiotic preparations
  • Other clinical presentations of C. diff
  • Antibiotic stewardship
  • When to call a surgeon

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses Macular Degeneration

OSUWexnerbloglogo2014 CME Webcast Discusses Macular Degeneration. On this CME webcast, we’re going to update you on the current approaches to the diagnosis and treatment of macular degeneration. Let me welcome today’s guests. Dr. Matthew Ohr is an Associate Professor of Ophthalmology and the Interim Chairman of the Department of Ophthalmology. And Dr. Fatoumata Yanoga is a retinal specialist and Assistant Professor of Ophthalmology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW Characteristics of Age-Related Macular Degeneration; DISCUSS Modifiable Risk Factors that can Lead to Prevention of Disease; DEFINE neovascular macular degeneration; and DISCUSS the diagnosis and management of wet macular degeneration.

You’ll also learn about the following:

  • Risk factors for macular degeneration
  • Prognosis of macular degeneration
  • Screening for macular degeneration in the primary care office
  • Assessing risks when starting a patient on anticoagulation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn the Latest on Hepatocellular Carcinoma Viewing CME Webcast

OSUWexnerbloglogo2014 Learn the Latest on Hepatocellular Carcinoma Viewing CME Webcast. Here in the United States, the incidence of hepatocellular carcinoma is rising. The way that we approach cancer of the liver has changed over the past 20 years and today on MedNet, we are going to bring you up to date on the epidemiology, screening, diagnosis, and treatment of hepatocellular carcinoma. Joining us today is hepatologist and Assistant Professor of Internal Medicine, Dr. Lanla F. Conteh.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the epidemiology of hepatocellular carcinoma in the United States; and RECOGNIZE which patients should be screened for hepatocellular carcinoma.

You’ll also learn about the following:

  • The rising incidence of hepatocellular carcinoma
  • New directions in treatment of hepatocellular carcinoma
  • Imaging test of choice in suspected hepatocellular carcinoma
  • How to biopsy suspected hepatocellular carcinoma
  • Viral hepatitis risk factors for hepatocellular carcinoma
  • Fibrolamellar hepatocellular carcinoma

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses Common Post-Operative Complications

OSUWexnerbloglogo2014 CME Webcast Discusses Common Post-Operative Complications. On this CME webcast, we’re going to take a closer look at post-operative complications: which ones are most common, how you recognize them, and what we can all do to prevent them. Joining our moderator, Dr. Jim Allen, in the studio are 2 experts from the Ohio State University in preventing surgical complications. Dr. David Evans is an Associate Professor of Surgery and is the director of the Ohio State University level 1 trauma center. And Dr. Benjamin Poulose is Professor of Surgery and the Director of the Division of General and Gastrointestinal Surgery.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: INTRODUCE Enhanced Recovery After Surgery (ERAS pathways); DISCUSS preoperative optimization to reduce surgical site infection and other complications; IDENTIFY characteristics associated with wound infection after surgery; and : IDENTIFY disease processes associated with Abdominal Core Health.

You’ll also learn about the following:

  • Common signs and symptoms of surgical wound infections
  • The role of the primary care provider in preventing surgical complications
  • Obesity and surgical risk
  • Pros and cons of mesh in hernia repair
  • Advantages of using a robot in hernia surgery
  • How long to wait to do elective surgery after a person quits smoking
  • Opioid addiction as a post-operative complication
  • Chlorhexidine bathing
  • Choosing a surgical closure method

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Colorectal Cancer Treatment on CME Webcast

OSUWexnerbloglogo2014 Learn About Colorectal Cancer Treatment on CME Webcast. We’ve heard a lot about colon cancer over the past few years on MedNet but mainly on screening for it. On this CME webcast, you’re going to hear about the treatment for colon cancer. We’re pleased to welcome colorectal surgeon and Assistant Professor of Surgery here at The Ohio State University, Dr. Syed Husain.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: LEARN basic concepts of colon and rectal cancer treatment; and IDENTIFY the differences in treatment approach between colon and rectal cancers.

You’ll also learn about the following:

  • Incidence of colorectal cancer
  • Risk factors for colorectal cancer
  • Colorectal cancer without precursor polyps
  • Different types of polyps
  • Prophylactic colectomy
  • The barium enema in 2018
  • Patterns of metastasis
  • Who gets a colostomy
  • What patients should expect after a partial colectomy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.